Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance Foundation Trials, LLC.
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Washington University School of Medicine
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
City of Hope Medical Center
Peking University Third Hospital
University of Washington
The Lymphoma Academic Research Organisation
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
Emory University
Sun Yat-sen University
The Lymphoma Academic Research Organisation
Masonic Cancer Center, University of Minnesota
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
H. Lee Moffitt Cancer Center and Research Institute
Ruijin Hospital
Fondazione Italiana Linfomi - ETS
University of Utah
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Washington
Alliance for Clinical Trials in Oncology
University of California, San Francisco
University of Washington
Fondazione Italiana Linfomi - ETS
Tianjin Medical University Cancer Institute and Hospital
Ruijin Hospital
PrECOG, LLC.
Emory University